logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Riboscience LLC


USPTO Granted Patents = 12

% Expired Patents = 16.7



Forward Citations = 18

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Klaus G Klumpp (10 out of 12 patents)

silverMedal Mark Smith (10 out of 51 patents)

bronzeMedal Zhuming Zhang (2 out of 29 patents)

4.  Jing Zhang (2 out of 15 patents)

5.  Francisco Xavier Talamas (1 out of 32 patents)

6.  Ronald Hawley (1 out of 1 patent)

7.  David Bernard Smith (89 patents)

8.  Klaus Klumpp (1 patent)

9.  Jing Zhang (0 patent)

10.  Joseph Armstrong Martin (0 patent)

11.  Christopher Mcguigan (0 patent)


12 patents:

1. 12029744 - Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors (2024-07-09),
2. 11351186 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2022-06-07),
3. 10953030 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2021-03-23),
4. 10682369 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2020-06-16),
5. 10358458 - 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication (2019-07-23),
6. 10092649 - 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication (2018-10-09),
7. 9895442 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2018-02-20),
8. 9708357 - 4'-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication (2017-07-18),
9. 9694028 - 4'-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication (2017-07-04),
10. 9370569 - 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication (2016-06-21),
11. 9249176 - 4'-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication (2016-02-02),
12. 9108999 - 2', 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2015-08-18),
Riboscience LLC, based in Palo Alto, CA, specializes in the development of innovative RNA-targeted therapeutics. The company focuses on harnessing the potential of ribonucleic acid (RNA) to create novel treatment modalities for various diseases, leveraging advanced biotechnological approaches. Riboscience is committed to advancing the understanding of RNA biology and its applications in medicine, positioning itself at the forefront of the biotechnology sector with a strong emphasis on research and development.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#146 in Palo Alto, CA

#6,060 in California

#25,540 in US

#48,129 in the World

Palo Alto, CA (US)
Palo Alto, CA, United States of America

Riboscience LLC

Forward Citations = 18

6 inventors:

goldMedal Klaus G Klumpp (10 out of 12 patents)

silverMedal Mark Smith (10 out of 51 patents)

bronzeMedal Zhuming Zhang (2 out of 29 patents)

4.  Jing Zhang (2 out of 15 patents)

5.  Francisco Xavier Talamas (1 out of 32 patents)

Please report any incorrect information to [email protected]
Loading…